BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 22, 2008
View Archived Issues
Adoptive transfer of T cells loaded with oncolytic virus effective in eliminating cancer metastasis
Read More
Endothelial progenitor cells regulate the angiogenic switch in lung metastasis model
Read More
Promising preclinical results of novel broadly neutralizing antibodies against HCV infection
Read More
Eisai granted early termination of statutory waiting period in acquisition of MGI
Read More
Novel therapeutic agents for hematologic disorders reported in recent patent literature
Read More
Adherex initiates phase IIb clinical trial of ADH-1 for melanoma
Read More
Senexis secures new funding to develop innovative compounds for AD
Read More
Angiotech and Symphony enter licensing agreement for PEG-based biomaterials
Read More
Primary endpoint met in phase II trial of 2PX for osteoarthritis
Read More
Peptimmune completes first close of series D preferred stock offering
Read More
Genaera initiates phase I trial of trodusquemine in overweight and obese diabetic patients
Read More
Preclinical characterization of aripiprazole shows uniqueness of D2 partial agonists
Read More
Cleveland BioLabs' Protectan CBLB-502 not selected for defense contract award
Read More
Diamyd submits application to initiate phase III studies of Diamyd in Sweden
Read More
Decreased VLDLR expression may be a biomarker for schizophrenia
Read More
Cerepro phase III trial results expected in July 2008
Read More
FDA committee to consider two injectable antibiotics from Theravance and J&J
Read More
GSK will not option XL-784 for further development
Read More
Recent Novartis patent discloses novel antiasthmatic agents
Read More
Schering-Plough and Shionogi launch Claritin dry syrup 1%
Read More
Motilin receptor agonists described in recent GSK patent
Read More
Roche and Ventana sign definitive merger agreement
Read More
Promising results for GW cannabinoid treatments for diabetes and metabolic disorders
Read More
Progress from Arpida's pivotal phase III trial of TLT treatment in onychomycosis
Read More
New treatment option for psoriasis imparted in recent Nippon Shinyaku patent
Read More